Health & bio

Biotech M&A blitz: seven deals in one week

BioCentury tallied seven biotech M&A announcements in early May—three exceeding $1B. H1 2026 reached 19 deals; CareDx acquired liquid-biopsy firm Naveris as the sole US buyer. Momentum accelerates post-Q1's record $15.6B deal volume.

Primary sources · 2
BioCenturyFiercePharma
← View the full 2026-05-11 (Mon) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →